Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects
- PMID: 3190187
- PMCID: PMC175926
- DOI: 10.1128/AAC.32.10.1590
Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects
Abstract
The pharmacokinetics of ofloxacin were investigated in eight healthy male volunteers. A single infusion (200 mg over 0.5 h) was performed on day 1, followed by a washout period of 2 weeks. Repeated administrations were performed for 4 days (200 mg every 12 h). Pharmacokinetic parameters were determined from the plasma decay curves of the single and the last of the multiple administrations. Ofloxacin kinetics after the single dose were best described by a two-phase curve with a total body clearance of 241.6 +/- 43.3 ml min-1, a volume of distribution of 112 +/- 23.1 liters, and an elimination half-life of 5.4 +/- 0.8 h. The extrapolated area under the curve (AUC0-infinity) was 14 +/- 2.3 mg.h liter-1. The pharmacokinetics were not significantly modified by repeated administration, demonstrated mainly by the AUC0-12 value of the last infusion (13.4 +/- 2.2 mg.h liter-1). We conclude that, with intravenous multiple doses every 12 h, the steady state is reached within 24 to 36 h and no abnormal accumulation or changes in pharmacokinetic parameters occur.
Similar articles
-
Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.Antimicrob Agents Chemother. 1996 Sep;40(9):2167-72. doi: 10.1128/AAC.40.9.2167. Antimicrob Agents Chemother. 1996. PMID: 8878600 Free PMC article. Clinical Trial.
-
Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.Antimicrob Agents Chemother. 1998 Apr;42(4):885-8. doi: 10.1128/AAC.42.4.885. Antimicrob Agents Chemother. 1998. PMID: 9559801 Free PMC article. Clinical Trial.
-
Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.Antimicrob Agents Chemother. 1994 Aug;38(8):1849-53. doi: 10.1128/AAC.38.8.1849. Antimicrob Agents Chemother. 1994. PMID: 7986019 Free PMC article.
-
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.Antimicrob Agents Chemother. 1992 Feb;36(2):308-12. doi: 10.1128/AAC.36.2.308. Antimicrob Agents Chemother. 1992. PMID: 1605596 Free PMC article. Clinical Trial.
-
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.J Antimicrob Chemother. 1988 Sep;22 Suppl C:73-9. doi: 10.1093/jac/22.supplement_c.73. J Antimicrob Chemother. 1988. PMID: 3182465
Cited by
-
Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis.Antimicrob Agents Chemother. 1996 Jul;40(7):1589-93. doi: 10.1128/AAC.40.7.1589. Antimicrob Agents Chemother. 1996. PMID: 8807045 Free PMC article.
-
Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.Antimicrob Agents Chemother. 1996 Sep;40(9):2167-72. doi: 10.1128/AAC.40.9.2167. Antimicrob Agents Chemother. 1996. PMID: 8878600 Free PMC article. Clinical Trial.
-
Ofloxacin pharmacokinetics in mechanically ventilated patients.Antimicrob Agents Chemother. 1991 Aug;35(8):1582-5. doi: 10.1128/AAC.35.8.1582. Antimicrob Agents Chemother. 1991. PMID: 1929329 Free PMC article.
-
High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.Antimicrob Agents Chemother. 1991 Dec;35(12):2558-61. doi: 10.1128/AAC.35.12.2558. Antimicrob Agents Chemother. 1991. PMID: 1810189 Free PMC article.
-
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.Antimicrob Agents Chemother. 1991 Feb;35(2):384-6. doi: 10.1128/AAC.35.2.384. Antimicrob Agents Chemother. 1991. PMID: 2024973 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous